Role of the GABAB receptor system in alcoholism and stress: focus on clinical studies and treatment perspectives

Alcohol

Volumn 43, Issue 7, 2009, Pages 559-563

  Addolorato, Giovanni ^a   Leggio, Lorenzo ^a,b   Cardone, Silvia ^a   Ferrulli, Anna ^a   Gasbarrini, Giovanni ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b BROWN UNIVERSITY   (United States)

Author keywords

Alcohol dependence; Anxiety; Baclofen; Craving; GABA; Stress

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; BACLOFEN; DIAZEPAM; PLACEBO;

ALCOHOL WITHDRAWAL; ALCOHOLISM; CLINICAL TRIAL; DELIRIUM TREMENS; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG TOLERABILITY; GABAERGIC SYSTEM; HUMAN; LIMBIC SYSTEM; LIVER CIRRHOSIS; NEUROENDOCRINE SYSTEM; NONHUMAN; OPTIMAL DRUG DOSE; REVIEW; STRESS; SYMPTOM;

ALCOHOLISM; ANIMALS; BACLOFEN; HUMANS; RECEPTORS, GABA-B; STRESS, PSYCHOLOGICAL;

EID: 70350746494     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.alcohol.2009.09.031     Document Type: Review

References (41)

1. Addolorato G., Caputo F., Capristo E., Colombo G., Gessa G.L., and Gasbarrini G. Ability of baclofen in reducing alcohol craving and intake: II-Preliminary clinical evidence. Alcohol. Clin. Exp. Res. 24 (2000) 67-71
2. Addolorato G., Caputo F., Capristo E., Domenicali M., Bernardi M., Janiri L., et al. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double blind randomized controlled study. Alcohol Alcohol. 37 (2002) 504-508
3. Addolorato G., Caputo F., Capristo E., Janiri L., Bernardi M., Agabio R., et al. Rapid suppression of alcohol withdrawal syndrome by baclofen. Am. J. Med. 112 (2002) 226-229
4. Addolorato G., Leggio L., Abenavoli L., DeLorenzi G., Parente A., Caputo F., et al. Suppression of alcohol delirium tremens by baclofen administration: a case-report. Clin. Neuropharmacol. 26 (2003) 258-262
5. Addolorato G., Abenavoli L., Leggio L., and Gasbarrini G. How many craving? Pharmacological aspects of craving treatment in alcohol addiction: a review. Neuropsychobiology 51 (2005) 59-66
6. Addolorato G., Leggio L., Abenavoli L., Agabio R., Caputo F., Capristo E., et al. Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. Am. J. Med. 119 (2006) 276.e13-276.e18
7. Addolorato G., Leggio L., Agabio R., Colombo G., and Gasbarrini G. Baclofen: a new drug for the treatment of alcohol dependence. Int. J. Clin. Pract. 60 (2006) 1003-1008
8. Addolorato G., Leggio L., Ferrulli A., Cardone S., Vonghia L., Mirijello A., et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet 370 (2007) 1915-1922
9. Addolorato G., Russell M., Albano E., Haber P.S., Wands J.R., and Leggio L. Understanding and treating patients with alcoholic cirrhosis: an update. Alcohol. Clin. Exp. Res. 33 (2009) 1136-1144
10. Ameisen O. Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician. Alcohol Alcohol. 40 (2005) 147-150
11. Anton R.F., Moak D.H., and Latham P. The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol. Clin. Exp. Res. 19 (1995) 92-99
12. Bormann J. The 'ABC' of GABA receptors. Trends Pharmacol. Sci. 21 (2000) 16-19
13. Bucknam W. Suppression of symptoms of alcohol dependence and craving using high-dose baclofen. Alcohol Alcohol. 42 (2007) 158-160
14. Colombo G., Addolorato G., Agabio R., Carai M.A., Pibiri F., Serra S., et al. Role of GABA(B) receptor in alcohol dependence: reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics. Neurotox. Res. 6 (2004) 403-414
15. Cryan J.F., and Kaupmann K. Don't worry 'B' happy!: a role for GABA(B) receptors in anxiety and depression. Trends Pharmacol. Sci. 26 (2005) 36-43
16. Flannery B.A., Garbutt J.C., Cody M.W., Renn W., Grace K., Osborne M., et al. Baclofen for alcohol dependence: a preliminary open-label study. Alcohol. Clin. Exp. Res. 28 (2004) 1517-1523
17. Garbutt J.C., Kampov-Polevoy A., Flannery B., Kalka-Juhl L., and Gallop R. Placebo-controlled trial of baclofen in alcohol dependence. Alcohol. Clin. Exp. Res. 31 s2 (2007) 61A [abstract at the 30th Annual Scientific Meeting of the Research Society on Alcoholism (RSA); Chicago, IL, 2007]
18. Garbutt J.C. The state of pharmacotherapy for the treatment of alcohol dependence. J. Subst. Abuse Treat. 36 (2009) S15-S23
19. Hall W., and Zador D.Z. The alcohol withdrawal syndrome. Lancet 349 (1997) 1897-1900
20. Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J. Psychiatr. Res. 33 (1999) 181-214
21. Knapp D.J., Overstreet D.H., and Breese G.R. Baclofen blocks expression and sensitization of anxiety-like behavior in an animal model of repeated stress and ethanol withdrawal. Alcohol. Clin. Exp. Res. 31 (2007) 582-595
22. Kraemer K.L., Mayo-Smith M.F., and Calkins D.R. Impact of age on the severity, course, and complications of alcohol withdrawal. Arch. Intern. Med. 157 (1997) 2234-2241
23. Krupitsky E.M., Burakov A.M., Ivanov V.B., Krandashova G.F., Lapin I.P., Grinenko A.J., et al. Baclofen administration for the treatment of affective disorders in alcoholic patients. Drug Alcohol Depend. 33 (1993) 157-163
24. Koob G.F. Alcoholism: allostasis and beyond. Alcohol. Clin. Exp. Res. 27 (2003) 232-243
25. Koob G.F. A role for GABA mechanisms in the motivational effects of alcohol. Biochem. Pharmacol. 68 (2004) 1515-1525
26. Leggio L., Ferrulli A., Cardone S., Malandrino N., Mirijello A., D'Angelo C., et al. Relationship between the hypothalamic-pituitary-thyroid axis and alcohol craving in alcohol-dependent patients. A longitudinal study. Alcohol. Clin. Exp. Res. 32 (2008) 2047-2053
27. Leggio L., Ferrulli A., Cardone S., Miceli A., Kenna G.A., Gasbarrini G., et al. Renin and aldosterone but not the natriuretic peptide correlate with obsessive craving in medium-term abstinent alcoholic patients: a longitudinal study. Alcohol 42 (2008) 375-381
28. Leggio L., Ferrulli A., Malandrino N., Miceli A., Capristo E., Gasbarrini G., et al. Insulin but not insulin growth factor-1 correlates with craving in currently drinking alcohol-dependent patients. Alcohol. Clin. Exp. Res. 32 (2008) 450-458
29. Leggio L., Kenna G.A., Fenton M., Bonenfant E., and Swift R.M. Typologies of alcohol dependence. From Jellinek to genetics and beyond. Neuropsychol. Rev. 19 (2009) 115-129
30. Leggio L., Kenna G.A., and Swift R.M. New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications. Prog. Neuropsychopharmacol. Biol. Psychiatry 32 (2008) 1106-1117
31. Leggio L., Malandrino N., Ferrulli A., Cardone S., Miceli A., Gasbarrini G., et al. Is cortisol involved in the alcohol-related fat mass impairment? A longitudinal clinical study. Alcohol Alcohol. 44 (2009) 211-215
32. Maccioni P., and Colombo G. Role of the GABAB receptor in alcohol seeking and drinking behavior: focus on preclinical studies. Alcohol 43 (2009) 555-558
33. Merikangas K.R., Mehta R.L., Molnar B.E., Walters E.E., Swendsen J.D., Aguilar-Gaziola S., et al. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict. Behav. 23 (1998) 893-907
34. Millan M.J. The neurobiology and control of anxious states. Prog. Neurobiol. 70 (2003) 83-244
35. Mombereau C., Kaupmann K., Froestl W., Sansig G., van der Putten H., and Cryan J.F. Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety and antidepressant-like behavior. Neuropsychopharmacology 29 (2004) 1050-1062
36. O'Connor P.G., and Schotternfeld R.S. Patients with alcohol problems. N. Engl. J. Med. 338 (1998) 592-602
37. Sajdyk T.J., Shekhar A., Donald R., and Gehlert D.R. Interactions between NPY and CRF in the amygdale to regulate emotionality. Neuropeptides 38 (2004) 225-234
38. Sinha R. How does stress increase risk of drug abuse and relapse?. Psychopharmacology 158 (2001) 343-359
39. Stallings W., and Schrader S. Baclofen as prophylaxis and treatment for alcohol withdrawal: a retrospective chart review. J. Okla. State Med. Assoc. 100 (2007) 354-360
40. Swift R.M., and Stout R.L. The relationship between craving, anxiety, and other symptoms in opioid withdrawal. J. Subst. Abuse 4 (1992) 19-26
41. Verheul R., van den Brink W., and Geerlings P. A three-pathway psychobiological model of craving for alcohol. Alcohol Alcohol. 34 (1999) 197-222